Neuralink opens recruitment for first-in-human PRIME Study
Evidence notes
- Neuralink opened recruitment for its first-in-human PRIME Study at its first hospital site.
- The study targets people with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis.
- Neuralink described the study as evaluating the investigational N1 Implant and R1 Robot system.
Company context
Neuralink develops implantable brain-computer interfaces and the R1 surgical robot used to place ultra-fine electrode threads.